NCT07710625 "Turkish Validity and Reliability of the Temperature Sensitivity Scale for Individuals With Parkinson's Disease"
| NCT ID | NCT07710625 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Acibadem University |
| Condition | Parkinson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-05-25 |
| Primary Completion | 2026-12-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-05-25 with a primary completion date of 2026-12-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to examine the validity and reliability of the Turkish version of the Temperature Sensitivity Scale in individuals with Parkinson's disease. This cross-sectional methodological study will evaluate the psychometric properties of the scale, including internal consistency, test-retest reliability, and construct validity, in order to provide a valid and reliable tool for assessing temperature sensitivity in Turkish-speaking individuals with Parkinson's disease.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of Parkinson's disease Hoehn and Yahr stage 1-3 Age between 40 and 85 years Mini-Mental State Examination (MMSE) score ≥ 24 Sufficient cognitive function to communicate and complete assessments Patients attending the Movement Disorders Outpatient Clinic of the Neurology Department Willingness to participate and provide written informed consent Exclusion Criteria: * Presence of psychiatric disorders (e.g., major depression or psychotic disorders) Diagnosis of advanced dementia Presence of uncontrolled systemic chronic diseases (e.g., diabetes mellitus or hypertension) Presence of severe cardiovascular or respiratory conditions Presence of additional orthopedic or neurological conditions that may affect test performance Severe visual or hearing impairments that could interfere with assessments Inability to cooperate adequately with the physiotherapist during assessments
Frequently Asked Questions
Who can join the NCT07710625 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 85 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07710625 currently recruiting?
Yes, NCT07710625 is actively recruiting participants. Visit ClinicalTrials.gov or contact Acibadem University to inquire about joining.
Where is the NCT07710625 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07710625 clinical trial?
NCT07710625 is sponsored by Acibadem University. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.